Genome of recombinant herpes virus, herpes virus, pharmaceutical composition, use of herpes virus or pharmaceutical composition, and methods for expressing, intensifying, increasing, amplifying and / or supplementing the levels of a polypeptide in one or more cells of an eye, to provide prophylactic, palliative or therapeutic relief of one or more signs or symptoms of an eye condition or disease and to treat an eye condition or disease.
BR112025022098A2Pending Publication Date: 2026-09-08
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- BR112025022098
- Authority / Receiving Office
- BR · BR
- Patent Type
- Applications
- Publication Date
- 2026-09-08
Smart Images

Figure 00000000_0000_ABST
Need to check novelty before this filing date? Find Prior Art
No text content released.